Publicacions en col·laboració amb investigadors/es de Princess Royal Hospital (2)

2007

  1. Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: Results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up

    Prostate Cancer and Prostatic Diseases, Vol. 10, Núm. 1, pp. 87-93

2005

  1. Bicalutamide ('Casodex') 150mg in addition to standard care in patients with nonmetastatic prostate cancer: Updated results from a randomised double-blind phase III study (median follow-up 5.1y) in the early prostate cancer programme

    Prostate Cancer and Prostatic Diseases, Vol. 8, Núm. 2, pp. 194-200